Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Control of Metastasis by NK Cells.

Identifieur interne : 004C97 ( Ncbi/Merge ); précédent : 004C96; suivant : 004C98

Control of Metastasis by NK Cells.

Auteurs : Alejandro L Pez-Soto [Espagne] ; Segundo Gonzalez [Espagne] ; Mark J. Smyth [Australie] ; Lorenzo Galluzzi [France]

Source :

RBID : pubmed:28810142

Descripteurs français

English descriptors

Abstract

The metastatic spread of malignant cells to distant anatomical locations is a prominent cause of cancer-related death. Metastasis is governed by cancer-cell-intrinsic mechanisms that enable neoplastic cells to invade the local microenvironment, reach the circulation, and colonize distant sites, including the so-called epithelial-to-mesenchymal transition. Moreover, metastasis is regulated by microenvironmental and systemic processes, such as immunosurveillance. Here, we outline the cancer-cell-intrinsic and -extrinsic factors that regulate metastasis, discuss the key role of natural killer (NK) cells in the control of metastatic dissemination, and present potential therapeutic approaches to prevent or target metastatic disease by harnessing NK cells.

DOI: 10.1016/j.ccell.2017.06.009
PubMed: 28810142

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:28810142

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Control of Metastasis by NK Cells.</title>
<author>
<name sortKey="L Pez Soto, Alejandro" sort="L Pez Soto, Alejandro" uniqKey="L Pez Soto A" first="Alejandro" last="L Pez-Soto">Alejandro L Pez-Soto</name>
<affiliation wicri:level="1">
<nlm:affiliation>Departamento de Biología Funcional, Área de Inmunología, Universidad de Oviedo, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), 33006 Oviedo, Asturias, Spain. Electronic address: lopezsalejandro@uniovi.es.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Departamento de Biología Funcional, Área de Inmunología, Universidad de Oviedo, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), 33006 Oviedo, Asturias</wicri:regionArea>
<wicri:noRegion>Asturias</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gonzalez, Segundo" sort="Gonzalez, Segundo" uniqKey="Gonzalez S" first="Segundo" last="Gonzalez">Segundo Gonzalez</name>
<affiliation wicri:level="1">
<nlm:affiliation>Departamento de Biología Funcional, Área de Inmunología, Universidad de Oviedo, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), 33006 Oviedo, Asturias, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Departamento de Biología Funcional, Área de Inmunología, Universidad de Oviedo, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), 33006 Oviedo, Asturias</wicri:regionArea>
<wicri:noRegion>Asturias</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Smyth, Mark J" sort="Smyth, Mark J" uniqKey="Smyth M" first="Mark J" last="Smyth">Mark J. Smyth</name>
<affiliation wicri:level="1">
<nlm:affiliation>Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006</wicri:regionArea>
<wicri:noRegion>QLD 4006</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Galluzzi, Lorenzo" sort="Galluzzi, Lorenzo" uniqKey="Galluzzi L" first="Lorenzo" last="Galluzzi">Lorenzo Galluzzi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Radiation Oncology, Weill Cornell Medical College, New York, NY 10065, USA; Sandra and Edward Meyer Cancer Center, New York, NY 10065, USA; Université Paris Descartes/Paris V, 75006 Paris, France. Electronic address: deadoc@vodafone.it.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Radiation Oncology, Weill Cornell Medical College, New York, NY 10065, USA; Sandra and Edward Meyer Cancer Center, New York, NY 10065, USA; Université Paris Descartes/Paris V, 75006 Paris</wicri:regionArea>
<wicri:noRegion>75006 Paris</wicri:noRegion>
<placeName>
<settlement type="city">Paris</settlement>
<region type="région" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28810142</idno>
<idno type="pmid">28810142</idno>
<idno type="doi">10.1016/j.ccell.2017.06.009</idno>
<idno type="wicri:Area/PubMed/Corpus">000790</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000790</idno>
<idno type="wicri:Area/PubMed/Curation">000787</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000787</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000787</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000787</idno>
<idno type="wicri:Area/Ncbi/Merge">004C97</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Control of Metastasis by NK Cells.</title>
<author>
<name sortKey="L Pez Soto, Alejandro" sort="L Pez Soto, Alejandro" uniqKey="L Pez Soto A" first="Alejandro" last="L Pez-Soto">Alejandro L Pez-Soto</name>
<affiliation wicri:level="1">
<nlm:affiliation>Departamento de Biología Funcional, Área de Inmunología, Universidad de Oviedo, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), 33006 Oviedo, Asturias, Spain. Electronic address: lopezsalejandro@uniovi.es.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Departamento de Biología Funcional, Área de Inmunología, Universidad de Oviedo, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), 33006 Oviedo, Asturias</wicri:regionArea>
<wicri:noRegion>Asturias</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gonzalez, Segundo" sort="Gonzalez, Segundo" uniqKey="Gonzalez S" first="Segundo" last="Gonzalez">Segundo Gonzalez</name>
<affiliation wicri:level="1">
<nlm:affiliation>Departamento de Biología Funcional, Área de Inmunología, Universidad de Oviedo, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), 33006 Oviedo, Asturias, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Departamento de Biología Funcional, Área de Inmunología, Universidad de Oviedo, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), 33006 Oviedo, Asturias</wicri:regionArea>
<wicri:noRegion>Asturias</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Smyth, Mark J" sort="Smyth, Mark J" uniqKey="Smyth M" first="Mark J" last="Smyth">Mark J. Smyth</name>
<affiliation wicri:level="1">
<nlm:affiliation>Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006</wicri:regionArea>
<wicri:noRegion>QLD 4006</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Galluzzi, Lorenzo" sort="Galluzzi, Lorenzo" uniqKey="Galluzzi L" first="Lorenzo" last="Galluzzi">Lorenzo Galluzzi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Radiation Oncology, Weill Cornell Medical College, New York, NY 10065, USA; Sandra and Edward Meyer Cancer Center, New York, NY 10065, USA; Université Paris Descartes/Paris V, 75006 Paris, France. Electronic address: deadoc@vodafone.it.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Radiation Oncology, Weill Cornell Medical College, New York, NY 10065, USA; Sandra and Edward Meyer Cancer Center, New York, NY 10065, USA; Université Paris Descartes/Paris V, 75006 Paris</wicri:regionArea>
<wicri:noRegion>75006 Paris</wicri:noRegion>
<placeName>
<settlement type="city">Paris</settlement>
<region type="région" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Cancer cell</title>
<idno type="eISSN">1878-3686</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Humans</term>
<term>Immunologic Surveillance</term>
<term>Immunotherapy</term>
<term>Killer Cells, Natural (immunology)</term>
<term>Neoplasm Metastasis (immunology)</term>
<term>Neoplasm Metastasis (pathology)</term>
<term>Neoplasm Metastasis (prevention & control)</term>
<term>Neoplasms (immunology)</term>
<term>Neoplasms (pathology)</term>
<term>Neoplasms (prevention & control)</term>
<term>Tumor Escape</term>
<term>Tumor Microenvironment</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Cellules tueuses naturelles (immunologie)</term>
<term>Humains</term>
<term>Immunothérapie</term>
<term>Microenvironnement tumoral</term>
<term>Métastase tumorale ()</term>
<term>Métastase tumorale (anatomopathologie)</term>
<term>Métastase tumorale (immunologie)</term>
<term>Surveillance immunologique</term>
<term>Tumeurs ()</term>
<term>Tumeurs (anatomopathologie)</term>
<term>Tumeurs (immunologie)</term>
<term>Échappement de la tumeur à la surveillance immunitaire</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Métastase tumorale</term>
<term>Tumeurs</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Cellules tueuses naturelles</term>
<term>Métastase tumorale</term>
<term>Tumeurs</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Killer Cells, Natural</term>
<term>Neoplasm Metastasis</term>
<term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Neoplasm Metastasis</term>
<term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Neoplasm Metastasis</term>
<term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Humans</term>
<term>Immunologic Surveillance</term>
<term>Immunotherapy</term>
<term>Tumor Escape</term>
<term>Tumor Microenvironment</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Humains</term>
<term>Immunothérapie</term>
<term>Microenvironnement tumoral</term>
<term>Métastase tumorale</term>
<term>Surveillance immunologique</term>
<term>Tumeurs</term>
<term>Échappement de la tumeur à la surveillance immunitaire</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The metastatic spread of malignant cells to distant anatomical locations is a prominent cause of cancer-related death. Metastasis is governed by cancer-cell-intrinsic mechanisms that enable neoplastic cells to invade the local microenvironment, reach the circulation, and colonize distant sites, including the so-called epithelial-to-mesenchymal transition. Moreover, metastasis is regulated by microenvironmental and systemic processes, such as immunosurveillance. Here, we outline the cancer-cell-intrinsic and -extrinsic factors that regulate metastasis, discuss the key role of natural killer (NK) cells in the control of metastatic dissemination, and present potential therapeutic approaches to prevent or target metastatic disease by harnessing NK cells.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">28810142</PMID>
<DateCreated>
<Year>2017</Year>
<Month>08</Month>
<Day>15</Day>
</DateCreated>
<DateCompleted>
<Year>2017</Year>
<Month>09</Month>
<Day>11</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>09</Month>
<Day>11</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1878-3686</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>32</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2017</Year>
<Month>Aug</Month>
<Day>14</Day>
</PubDate>
</JournalIssue>
<Title>Cancer cell</Title>
<ISOAbbreviation>Cancer Cell</ISOAbbreviation>
</Journal>
<ArticleTitle>Control of Metastasis by NK Cells.</ArticleTitle>
<Pagination>
<MedlinePgn>135-154</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S1535-6108(17)30260-X</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ccell.2017.06.009</ELocationID>
<Abstract>
<AbstractText>The metastatic spread of malignant cells to distant anatomical locations is a prominent cause of cancer-related death. Metastasis is governed by cancer-cell-intrinsic mechanisms that enable neoplastic cells to invade the local microenvironment, reach the circulation, and colonize distant sites, including the so-called epithelial-to-mesenchymal transition. Moreover, metastasis is regulated by microenvironmental and systemic processes, such as immunosurveillance. Here, we outline the cancer-cell-intrinsic and -extrinsic factors that regulate metastasis, discuss the key role of natural killer (NK) cells in the control of metastatic dissemination, and present potential therapeutic approaches to prevent or target metastatic disease by harnessing NK cells.</AbstractText>
<CopyrightInformation>Copyright © 2017 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>López-Soto</LastName>
<ForeName>Alejandro</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Biología Funcional, Área de Inmunología, Universidad de Oviedo, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), 33006 Oviedo, Asturias, Spain. Electronic address: lopezsalejandro@uniovi.es.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gonzalez</LastName>
<ForeName>Segundo</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Biología Funcional, Área de Inmunología, Universidad de Oviedo, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), 33006 Oviedo, Asturias, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Smyth</LastName>
<ForeName>Mark J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Galluzzi</LastName>
<ForeName>Lorenzo</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, Weill Cornell Medical College, New York, NY 10065, USA; Sandra and Edward Meyer Cancer Center, New York, NY 10065, USA; Université Paris Descartes/Paris V, 75006 Paris, France. Electronic address: deadoc@vodafone.it.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Cancer Cell</MedlineTA>
<NlmUniqueID>101130617</NlmUniqueID>
<ISSNLinking>1535-6108</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007157" MajorTopicYN="N">Immunologic Surveillance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007167" MajorTopicYN="N">Immunotherapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007694" MajorTopicYN="N">Killer Cells, Natural</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009362" MajorTopicYN="N">Neoplasm Metastasis</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019139" MajorTopicYN="N">Tumor Escape</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D059016" MajorTopicYN="Y">Tumor Microenvironment</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">ADCC</Keyword>
<Keyword MajorTopicYN="N">CTLA4</Keyword>
<Keyword MajorTopicYN="N">DNAM-1</Keyword>
<Keyword MajorTopicYN="N">NKG2D</Keyword>
<Keyword MajorTopicYN="N">PD-1</Keyword>
<Keyword MajorTopicYN="N">TGFB1</Keyword>
<Keyword MajorTopicYN="N">circulating tumor cells</Keyword>
<Keyword MajorTopicYN="N">disseminated tumor cells</Keyword>
<Keyword MajorTopicYN="N">immune checkpoint blockers</Keyword>
<Keyword MajorTopicYN="N">metastatic cascade</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2017</Year>
<Month>04</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2017</Year>
<Month>05</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2017</Year>
<Month>06</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2017</Year>
<Month>8</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2017</Year>
<Month>8</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>9</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">28810142</ArticleId>
<ArticleId IdType="pii">S1535-6108(17)30260-X</ArticleId>
<ArticleId IdType="doi">10.1016/j.ccell.2017.06.009</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Australie</li>
<li>Espagne</li>
<li>France</li>
</country>
<region>
<li>Île-de-France</li>
</region>
<settlement>
<li>Paris</li>
</settlement>
</list>
<tree>
<country name="Espagne">
<noRegion>
<name sortKey="L Pez Soto, Alejandro" sort="L Pez Soto, Alejandro" uniqKey="L Pez Soto A" first="Alejandro" last="L Pez-Soto">Alejandro L Pez-Soto</name>
</noRegion>
<name sortKey="Gonzalez, Segundo" sort="Gonzalez, Segundo" uniqKey="Gonzalez S" first="Segundo" last="Gonzalez">Segundo Gonzalez</name>
</country>
<country name="Australie">
<noRegion>
<name sortKey="Smyth, Mark J" sort="Smyth, Mark J" uniqKey="Smyth M" first="Mark J" last="Smyth">Mark J. Smyth</name>
</noRegion>
</country>
<country name="France">
<region name="Île-de-France">
<name sortKey="Galluzzi, Lorenzo" sort="Galluzzi, Lorenzo" uniqKey="Galluzzi L" first="Lorenzo" last="Galluzzi">Lorenzo Galluzzi</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004C97 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 004C97 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:28810142
   |texte=   Control of Metastasis by NK Cells.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:28810142" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024